Summary Measurement of marrow fat (MF) is important to the study of bone fragility. We measured MF on iliac biopsies and by spine/hip magnetic resonance spectroscopy in the same subjects. Noninvasively assessed spine MF and histomorphometrically assessed MF correlated well. MF quantity and relationships with bone volume differed by measurement site.
Introduction
Fat and bone interact at both the systemic and the local cellular level. Recent studies show that obesity, particularly abdominal obesity, is associated with lower bone mass [1] [2] [3] [4] [5] [6] [7] and increased fracture risk [8] [9] [10] [11] [12] . Several factors have been implicated as mediators of complex relationships between fat and bone, including sclerostin, insulin-like growth factor 1, adipokines, inflammatory cytokines, and lipids [1, 3, 7, 13] .
Fat and bone interactions may be particularly important at the local, bone marrow level. In the bone marrow, osteoblasts and adipocytes derive from a common mesenchymal precursor cell [14] . Recent work suggests that control of differentiation of this precursor cell into either an adipocyte or an osteoblast is an important determinant of bone structural integrity [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . A reciprocal relationship between marrow adipocytes and osteoblasts has been observed in osteoporosis related to aging, menopause, anorexia nervosa, glucocorticoids, and thiazolidinediones [15] [16] [17] [18] [19] [20] [21] [22] . Marrow fat may also suppress osteoblast proliferation and function through paracrine mechanisms involving local secretion of adipokines and fatty acids [25] . Some human imaging studies suggest that alterations in marrow fat may contribute to bone fragility and fracture risk independent of BMD [23, 24, 26] . Moreover, animal studies suggest that bone marrow adipocytes and osteoblasts are regulated independently [27] [28] [29] .
Marrow adipocytes can be quantified directly on transiliac crest bone biopsy samples [21, 30] , yielding measurements of adipocyte number, size, density, and percent of marrow volume. We have previously reported results from such analyses in 104 premenopausal women (64 with idiopathic osteoporosis (IOP), 40 controls). Those with IOP had significantly and substantially higher adipocyte number (by 22 %), size (by 24 %), and volume (by 26 %) than controls (p<0.0001 for all), even after adjusting for age, BMI, and trabecular bone volume fraction by micro-CT [30] .
Additionally, marrow fat can be measured noninvasively at the spine and hip using proton magnetic resonance spectroscopy ( 1 H-MRS), expressed as fat fraction (%) within a region of interest in the marrow space [2, 22, 31, 32] . Eleven of the 104 previously studied subjects [30] and 5 newly recruited subjects had 1 H-MRS in addition to transiliac biopsy. To our knowledge, this is the first study to examine relationships between marrow fat assessed by 1 H-MRS and marrow adipocytes measured on transiliac bone biopsy samples in the same subjects. We hypothesized that there would be strong, direct correlations between marrow fat measured by these different techniques at different anatomical sites.
Methods

Patient population
We studied 16 premenopausal women, aged 18-45 years, either enrolled in a larger cross-sectional, case-control transiliac bone biopsy study of 64 women with idiopathic osteoporosis (IOP) and 40 healthy controls or undergoing biopsy prior to teriparatide treatment for a study of teriparatide in IOP. Participation in the MRS substudy was offered to all 32 subjects who enrolled in the studies after the technique became available in 2009. Subjects were recruited at Columbia University Medical Center, New York, NY, and Creighton University, Omaha, NE. Inclusion and exclusion criteria for the IOP studies were previously reported [30, 33] . We defined premenopausal status as regular menses off hormonal contraception and early follicular phase follicle-stimulating hormone (FSH) levels <20 mIU/mL. In subjects and controls, secondary causes of osteoporosis were excluded by detailed history, physical, and biochemical evaluation: estrogen deficiency, All subjects provided written informed consent. The institutional review boards of both institutions approved these studies.
Areal BMD and body composition by DXA Areal BMD at the lumbar spine, total hip, femoral neck and distal radius, and whole body (excluding head) and trunk fat were measured by DXA (Discovery, Hologic Inc., Walton, MA) at Columbia and Creighton University Medical Centers as previously described [34] .
Transiliac bone biopsy
After double labeling with tetracycline, transiliac biopsy was performed using a Bordier-type trephine with an inner diameter of 7.5 mm [35] . The intact biopsy specimens were fixed and dehydrated in ethanol. Biopsy specimens were embedded i n p o l y m e t h y l m e t h a c r y l a t e f o r q u a n t i t a t i v e histomorphometry, sectioned (7 μm), and stained (Goldner trichrome) according to established procedures [36] . Histomorphometry was performed with a digitizing imageanalysis system (OsteoMeasure, Version 4.00C, OsteoMetrics, Inc, Atlanta, GA). All structural and remodeling variables were calculated according to American Society for Bone and Mineral Research recommendations [37] .
Biopsy-based adipocyte analyses
In biopsy specimens with an intact marrow/cancellous bone compartment and two cortices, adipocyte parameters were assessed in a blinded manner according to the method of Syed et al. [21] and as we have previously published [30] on sections stained with Goldner's trichrome. We analyzed a uniform number of fields in all sections. Each biopsy was oriented with the thinner of the two cortices at the top of the microscopic field. Starting at the farthest left-hand margin of the endocortical surface of the uppermost cortex, the observer moved three fields to the right and three fields down. This randomly selected field was the first of four fields (two consecutive fields on top followed by the two consecutive fields immediately below) that were analyzed with a ×20 objective using the OsteoMeasure analysis system (OsteoMetrics Inc., Decatur, IL). Fields with a significant artefact (e.g., a fold in the section) were excluded and the immediately adjacent field analyzed. The total tissue area of the four measurement fields at the magnification used (×200) was 1.09 mm To assess representativeness of adipocyte parameters, we compared two different areas of the biopsy sample (top, as previously described, and center) in ten subjects. Correlation coefficients between adipocyte parameters between the two regions ranged from 0.65 to 0.90 (p=0.0003-0.04) [30] , and intraclass correlation coefficients ranged from 0.59 to 0.85 (results not shown).
H-MRS
H-MRS acquisition
All MR images were acquired on a research-dedicated 1.5-T whole-body Signa "LX" MR system (General Electric, Milwaukee, WI) at Columbia University.
L3-vertebral 1 H-MRS
A spine array coil was used to acquire 1 H-MRS with the fifth coil (L5 coil) centered at L3 [32] . L3 was chosen because optimal coil positioning is facilitated by surface landmarks (iliac crests). After scout images in the transverse, coronal, and sagittal planes were acquired, T1-weighted transverse images (repetition time ms/echo time ms, 450/1; section thickness, 4 mm with 0.4-mm gap; field of view, 325 mm; matrix, 256 by 256; number of signals acquired, 2) were acquired to guide positioning of a volume of interest (VOI) within L3. VOI size is prescribed as one half of the height, width, and length of the L3 vertebra and ranges from 1.9 to 5.1 cm 
H-MRS
A body matrix-phased array coil was positioned over the pelvis region centered on the left great trochanter. A voxel measuring 12 × 12 × 12 mm (1.7 mL) was positioned within the proximal femoral metaphysis at the intertrochanteric region. A coronal image scout view was used to place the MRS voxel according to specific reproducible anatomical landmarks. In each subject, the center of the voxel was aligned linearly with the lower edge of the greater trochanter. This required voxel size was too large to allow assessment at the femoral neck site. Single voxel 1 H-MRS using the same non-watersuppressed PRESS pulse sequence was performed [22] .
Spectra acquired from L3 and the femur were exported and analyzed using a time-domain fitting routine known as Advanced Method for Accurate, Robust, and Efficient Spectral fitting (AMARES) of 1 H-MRS data with use of prior knowledge in the jMRUI software [32, 41] . Manually selected resonance frequency and line width of water (4.65 ppm) and fat (1.3 ppm) peaks were used as starting values in the nonlinear least square fitting algorithm. Vertebral body fat fraction, defined as the relative fat signal intensity amplitude in terms of a percentage of total signal intensity amplitude (S water and S fat ), was calculated according to the following equation [23] : Fat fraction=[S fat /(S fat +S water )].
Statistical methods
Statistical analyses were performed using SAS software (SAS Institute, Cary NC, USA). Correlation analyses were used to describe relationships between variables in this population. Because all marrow fat variables were normally distributed (Kolmogorov-Smirnov test), Pearson correlations were used. Multivariate linear regression analyses were used to control for covariates. All data are expressed as mean±standard deviation (SD). Results were considered significant with p<0.05.
Results
Marrow fat measurements on both biopsy samples and by 1 H-MRS were available in 16 subjects, 9 with IOP and 7 controls. Baseline characteristics are shown in Table 1 . Subjects and controls differed only in terms of BMD by DXA.
Measures of marrow fat at the three anatomical locations (spine and femur by 1 H-MRS (Fig. 1) , iliac crest on biopsy sample) show evidence of site-specific differences in the fraction (%) occupied by fat (Fig. 2) . Consistent with our earlier publication in a larger cohort, certain adipocyte parameters from transiliac biopsies (Ad.V/Ma.V and Ad.Ar) were significantly higher in women with IOP. Others (Ad.N, Ad.D, and Ad.Pm) and femoral marrow fat measures by 1 H-MRS tended to be higher in women with IOP than controls ( Table 1) .
Correlations between marrow fat by 1 
H-MRS and marrow fat assessed on biopsies
Fat fraction measured at L3 correlated positively and significantly with all marrow fat variables assessed on biopsies. In contrast, there were no correlations between fat fraction at the femur and marrow fat on biopsies (Fig. 3, Table 2 ). When IOP subjects and controls were examined separately, this finding was accentuated in the IOP subjects (Ad.V/Ma.V vs L3: r= 0.77, p = 0.02; vs femur: r = −0.09, p = 0.8), whereas no Fig. 1 MRS spectra of bone marrow fat. Subject 1 (a L3, b femur) has less bone marrow fat than subject 2 (c L3, d femur) Fig. 2 Fat fraction at the spine, femur, and iliac crest significant relationships were found in the controls (Ad.V/ Ma.V vs L3: r=0.25, p=0.6; vs femur: r=−0.52, p=0.2). Adjustment for age, BMI, and bone volume fraction did not attenuate the relationship between biopsy measures and L3 fat fraction (for Ad.V/Ma.V vs L3: R=0.67; p=0.01), and had no effect on the relationship with femur fat fraction.
Correlations between marrow fat, bone volume, and body fat BMD by DXA correlated inversely or tended to correlate inversely with marrow fat measures at all three sites (Table 3 ).
The strongest relationships were seen between femoral marrow fat and femoral BMD by DXA. Although some trends were seen for BMI, marrow fat did not correlate with DXA body fat measures.
Discussion
To our knowledge, this is the first study to evaluate relationships between marrow fat measured noninvasively by 1 H-MRS at L3 and the proximal femur and marrow fat assessed by quantitative histomorphometry on bone biopsy samples in the same subjects. We found positive and significant correlations between marrow fat fraction at L3 by 1 H-MRS and all marrow fat variables assessed on iliac crest biopsies. In contrast, we found no correlations between marrow fat fraction at the proximal femur and marrow fat on biopsies. In addition, we observed that the fraction (%) of marrow fat relative to total 1 H-MRS signal or tissue volume was markedly higher at the femur than the other two sites and that only marrow fat at the femur was inversely correlated with BMD by DXA.
We previously reported that, at the iliac crest, premenopausal women with IOP have significantly and substantially higher adipocyte number (by 22 %), size (by 24 %), and volume (by 26 %) than controls (p<0.0001 for all), even after adjusting for age, BMI, and trabecular bone volume fraction by micro-CT [30] . In this study, which includes 11 of the 104 previously reported and 5 additional subjects, we also found that marrow adipocyte parameters were higher (by 26 to 40 %) in women with IOP than controls. However, some differences, although larger than detected in our previous study, did not reach statistical significance, likely because of the smaller sample size. We also found that marrow fat by 1 H-MRS tended to be higher in women with IOP than controls, but more so at the proximal femur than at L3. Although the small sample size may explain the lack of significant differences seen by 1 H-MRS, it is also possible that IOP may have sitespecific effects on marrow adiposity.
As hypothesized, we found that marrow fat fraction on biopsy samples correlated positively and significantly with marrow fat fraction by 1 H-MRS at the L3 vertebra, particularly in the IOP subjects (r=0.77, p=0.02). However, contrary to our hypothesis, no relationships were detected between adipocyte parameters measured on biopsies and marrow fat fraction assessed by 1 H-MRS at the femur. Further investigations will be required to determine whether the mechanisms governing the marrow fat compartment may be site specific. One possible explanation for this centers on the site-specific differences in marrow composition. Both L3 and the iliac crest are rich in cancellous bone and filled with red, more hematopoietically active, marrow; in contrast, the intertrochanteric region is adjacent to the long-bone cavity that contains more yellow marrow [42] . Additional studies will be required to determine whether the yellow marrow fat fraction and red marrow fat fraction are regulated differently. Our previous study also showed that total body marrow fat (predominantly yellow marrow fat) showed weaker correlation with BMD than the red marrow-rich pelvic region [31] .
Several studies have documented inverse relationships between bone mass and marrow fat [22, 31, 38] . We previously reported that trabecular bone volume fraction by micro-CT on biopsies was inversely related to marrow fat measured on iliac crest biopsies in 39 healthy premenopausal women but not in 64 IOP subjects [30] . The inverse relationship between BMD by DXA and marrow fat that we observed in this considerably smaller study is consistent with prior reports [43] [44] [45] but we did not detect any significant relationships between bone volume fraction and marrow fat parameters, either in the group as a whole or in the subgroups. The small sample size may have limited our ability to detect the relationships.
Prior studies have shown that both obesity [2] and undernutrition/anorexia nervosa [22] are associated with higher marrow adiposity in premenopausal women. In this small but diverse sample, we did not detect significant relationships between body fat and marrow fat at any site.
This study has several limitations. Although the inclusion of both subjects affected and unaffected by osteoporosis permitted us to include a broad range of bone volumes, the sample size was likely too small to detect between group differences in the relationships between marrow fat and bone volume. Bone volume results presented here are based upon histomorphometry, not micro-CT, assessments. Only premenopausal women were studied, thus limiting generalizability to other populations such as children, postmenopausal women, and men.
In conclusion, we compared marrow fat assessments at three different sites in the same subjects, using both invasive biopsy and noninvasive 1 H-MRS techniques. Fat fraction measured at L3 correlated positively and significantly with all marrow fat variables assessed on transiliac biopsies, while no such correlations were seen with fat fraction at the femur. Additionally, we found site-specific differences in marrow fat quantity, and in the relationships between marrow fat and bone volume. Further investigation will be required to determine whether the regulation of marrow fat may be site specific. 
